The 2005-2010 World Outlook for Pharmacies and Drug Stores

1 INTRODUCTION
1.1 Overview
1.2 What is Latent Demand and the P.I.E.?
1.3 The Methodology
1.3.1 Step 1. Product Definition and Data Collection
1.3.2 Step 2. Filtering and Smoothing
1.3.3 Step 3. Filling in Missing Values
1.3.4 Step 4. Varying Parameter, Non-linear Estimation
1.3.5 Step 5. Fixed-Parameter Linear Estimation
1.3.6 Step 6. Aggregation and Benchmarking
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities
2 SUMMARY OF FINDINGS
2.1 The Worldwide Market Potential
3 AFRICA
3.1 Executive Summary
3.2 Algeria
3.3 Angola
3.4 Benin
3.5 Botswana
3.6 Burkina Faso
3.7 Burundi
3.8 Cameroon
3.9 Cape Verde
3.10 Central African Republic
3.11 Chad
3.12 Comoros
3.13 Congo (formerly Zaire)
3.14 Ivory coast
3.15 Djibouti
3.16 Egypt
3.17 Equatorial Guinea
3.18 Ethiopia
3.19 Gabon
3.20 Ghana
3.21 Guinea
3.22 Guinea-Bissau
3.23 Kenya
3.24 Lesotho
3.25 Liberia
3.26 Libya
3.27 Madagascar
3.28 Malawi
3.29 Mali
3.30 Mauritania
3.31 Mauritius
3.32 Morocco
3.33 Mozambique
3.34 Namibia
3.35 Niger
3.36 Nigeria
3.37 Republic of Congo
3.38 Reunion
3.39 Rwanda
3.40 Sao Tome E Principe
3.41 Senegal
3.42 Sierra Leone
3.43 Somalia
3.44 South Africa
3.45 Sudan
3.46 Swaziland
3.47 Tanzania
3.48 The Gambia
3.49 Togo
3.50 Tunisia
3.51 Uganda
3.52 Western Sahara
3.53 Zambia
3.54 Zimbabwe
4 ASIA, OCEANA & THE AMERICAS
4.1 Executive Summary
4.2 American Samoa
4.3 Antigua and Barbuda
4.4 Argentina
4.5 Aruba
4.6 Australia
4.7 Bahamas
4.8 Bangladesh
4.9 Barbados
4.10 Belize
4.11 Bermuda
4.12 Bhutan
4.13 Bolivia
4.14 Brazil
4.15 Brunei
4.16 Burma
4.17 Cambodia
4.18 Canada
4.19 Cayman Islands
4.20 Chile
4.21 China
4.22 Colombia
4.23 Costa Rica
4.24 Cuba
4.25 Dominica
4.26 Dominican Republic
4.27 Ecuador
4.28 El Salvador
4.29 Falkland Islands
4.30 Fiji
4.31 French Guiana
4.32 French Polynesia
4.33 Greenland
4.34 Grenada
4.35 Guadeloupe
4.36 Guam
4.37 Guatemala
4.38 Guyana
4.39 Haiti
4.40 Honduras
4.41 Hong Kong
4.42 India
4.43 Indonesia
4.44 Jamaica
4.45 Japan
4.46 Kiribati
4.47 Laos
4.48 Macau
4.49 Malaysia
4.50 Maldives
4.51 Martinique
4.52 Mexico
4.53 Mongolia
4.54 Nauru
4.55 Nepal
4.56 Netherlands Antilles
4.57 New Caledonia
4.58 New Zealand
4.59 Nicaragua
4.60 North Korea
4.61 Northern Mariana Island
4.62 Panama
4.63 Papua New Guinea
4.64 Paraguay
4.65 Peru
4.66 Philippines
4.67 Puerto Rico
4.68 Seychelles
4.69 Singapore
4.70 Solomon Islands
4.71 South Korea
4.72 Sri Lanka
4.73 St. Kitts and Nevis
4.74 St. Lucia
4.75 St. Vincent and the Grenadines
4.76 Suriname
4.77 Taiwan
4.78 Thailand
4.79 Tonga
4.80 Trinidad and Tobago
4.81 Tuvalu
4.82 United States
4.83 Uruguay
4.84 Vanuatu
4.85 Venezuela
4.86 Vietnam
4.87 Virgin Islands, US
4.88 Western Samoa
5 EUROPE
5.1 Executive Summary
5.2 Albania
5.3 Andorra
5.4 Austria
5.5 Belarus
5.6 Belgium
5.7 Bosnia and Herzegovina
5.8 Bulgaria
5.9 Croatia
5.10 Cyprus
5.11 Denmark
5.12 Estonia
5.13 Finland
5.14 France
5.15 Georgia
5.16 Germany
5.17 Greece
5.18 Hungary
5.19 Iceland
5.20 Ireland
5.21 Italy
5.22 Kazakhstan
5.23 Latvia
5.24 Liechtenstein
5.25 Lithuania
5.26 Luxembourg
5.27 Malta
5.28 Moldova
5.29 Monaco
5.30 Netherlands
5.31 Norway
5.32 Poland
5.33 Portugal
5.34 Romania
5.35 Russia
5.36 San Marino
5.37 Slovakia
5.38 Slovenia
5.39 Spain
5.40 Sweden
5.41 Switzerland
5.42 Ukraine
5.43 United Kingdom
6 THE MIDDLE EAST
6.1 Executive Summary
6.2 Afghanistan
6.3 Armenia
6.4 Azerbaijan
6.5 Bahrain
6.6 Iran
6.7 Iraq
6.8 Israel
6.9 Jordan
6.10 Kuwait
6.11 Kyrgyzstan
6.12 Lebanon
6.13 Oman
6.14 Pakistan
6.15 Qatar
6.16 Saudi Arabia
6.17 Syrian Arab Republic
6.18 Tajikistan
6.19 Turkey
6.20 Turkmenistan
6.21 United Arab Emirates
6.22 Uzbekistan
6.23 Yemen
7 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
7.1 Disclaimers & Safe Harbor
7.2 ICON Group Ltd. User Agreement Provisions